0001193125-20-154249.txt : 20200528 0001193125-20-154249.hdr.sgml : 20200528 20200528160610 ACCESSION NUMBER: 0001193125-20-154249 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20200528 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200528 DATE AS OF CHANGE: 20200528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zymeworks Inc. CENTRAL INDEX KEY: 0001403752 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38068 FILM NUMBER: 20921088 BUSINESS ADDRESS: STREET 1: 540-1385 WEST 8TH AVENUE CITY: Vancouver STATE: A1 ZIP: V6H 3V9 BUSINESS PHONE: (604) 678-1388 MAIL ADDRESS: STREET 1: 540-1385 WEST 8TH AVENUE CITY: Vancouver STATE: A1 ZIP: V6H 3V9 FORMER COMPANY: FORMER CONFORMED NAME: Zymeworks Inc DATE OF NAME CHANGE: 20070620 8-K 1 d935577d8k.htm 8-K 8-K
false 0001403752 false 0001403752 2020-05-28 2020-05-28

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 28, 2020

 

Zymeworks Inc.

(Exact name of registrant as specified in its charter)

 

British Columbia, Canada

 

001-38068

 

47-2569713

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

Suite 540, 1385 West 8th Avenue, Vancouver, British Columbia, Canada

V6H 3V9

(Address of principal executive offices)

 

(Zip Code)

(604) 678-1388

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Shares, no par value per share

 

ZYME

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


ITEM 7.01 REGULATION FD DISCLOSURE

On May 28, 2020, Zymeworks Inc. (the “Company”) issued a press release announcing that Zymeworks will present at the upcoming Jefferies 2020 Virtual Healthcare Conference taking place June 2-4, 2020. The Company’s presentation will be on Thursday, June 4, 2020 at 2:30 p.m. ET. On May 28, 2020, this press release was filed with the Canadian securities regulatory authorities in Canada on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com. A copy of this press release is attached as exhibit 99.1 hereto.

The information provided under this Item (including Exhibit 99.1, attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

                (d) Exhibits

Exhibit

No.

   

Description

         
 

99.1

   

Press Release dated May 28, 2020.

         
 

104

   

Cover Page Interactive Data File (embedded as Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

ZYMEWORKS INC.

 

 

(Registrant)

             

Date: May 28, 2020

 

 

By:

 

/s/ Neil A. Klompas

 

 

Name:

Title:

 

Neil A. Klompas

Executive Vice President, Business

Operations and Chief Financial Officer

EX-99.1 2 d935577dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

Zymeworks to Present at the Jefferies 2020 Virtual Healthcare Conference

Vancouver, Canada (May 28, 2020) – Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced that the Company will present at the upcoming Jefferies 2020 Virtual Healthcare Conference taking place June 2-4, 2020.

The Company’s presentation will be on Thursday, June 4, 2020 at 2:30 p.m. ET.

Interested parties can access a live webcast of the presentation via a link from Zymeworks’ website at http://ir.zymeworks.com/ events-and-presentations, which will also host a recorded replay available afterwards.

About Zymeworks Inc.

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks’ suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks’ lead clinical candidate, ZW25, is a novel Azymetric bispecific antibody currently in Phase 2 clinical development. Zymeworks’ second clinical candidate, ZW49, is a bispecific antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody framework of ZW25 with Zymeworks’ proprietary ZymeLink linker-cytotoxin. Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies. For more information, visit www.zymeworks.com.

Contacts:

Zymeworks Inc.

Investor Inquiries:

Ryan Dercho, Ph.D.

(604) 678-1388

ir@zymeworks.com

Tiffany Tolmie

(604) 678-1388

ir@zymeworks.com

Media Inquiries:

Kavita Shah, Ph.D.

(604) 678-1388

info@zymeworks.com

EX-101.SCH 3 zyme-20200528.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 zyme-20200528_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Country Entity Address, Country Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 zyme-20200528_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g935577g0528125705256.jpg GRAPHIC begin 644 g935577g0528125705256.jpg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ilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d935577d8k.htm d935577dex991.htm zyme-20200528.xsd zyme-20200528_lab.xml zyme-20200528_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Document and Entity Information
May 28, 2020
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001403752
Document Type 8-K
Document Period End Date May 28, 2020
Entity Registrant Name Zymeworks Inc.
Entity Incorporation State Country Code A1
Entity File Number 001-38068
Entity Tax Identification Number 47-2569713
Entity Address, Address Line One Suite 540, 1385 West 8th Avenue
Entity Address, City or Town Vancouver
Entity Address, State or Province BC
Entity Address, Country CA
Entity Address, Postal Zip Code V6H 3V9
City Area Code 604
Local Phone Number 678-1388
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Shares, no par value per share
Trading Symbol ZYME
Security Exchange Name NYSE
Entity Emerging Growth Company false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-20-154249-xbrl.zip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end XML 11 d935577d8k_htm.xml IDEA: XBRL DOCUMENT 0001403752 2020-05-28 2020-05-28 false 0001403752 false 8-K 2020-05-28 Zymeworks Inc. A1 001-38068 47-2569713 Suite 540, 1385 West 8th Avenue Vancouver BC CA V6H 3V9 604 678-1388 false false false false Common Shares, no par value per share ZYME NYSE false XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d935577d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d935577d8k.htm" ] }, "labelLink": { "local": [ "zyme-20200528_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "zyme-20200528_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "zyme-20200528.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "zyme", "nsuri": "http://www.zymeworks.com/20200528", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d935577d8k.htm", "contextRef": "duration_2020-05-28_to_2020-05-28", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d935577d8k.htm", "contextRef": "duration_2020-05-28_to_2020-05-28", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zymeworks.com//20200528/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" }